RNA viruses constitute the most abundant group of pathogens of man, an
imals and plants. They share high mutation rates which are in the rang
e 10(-3) to 10(-5) misincorporations per nucleotide site and round of
copying. This is due to the absence or low efficiency of proofreading-
repair or postreplicative repair activities associated with replicatin
g RNA. Populations of RNA viruses are extremely heterogeneous and form
dynamic mutant swarms termed viral quasispecies. This genetic organis
ation implies that any individual mutant has only a fleeting existence
; that is, RNA viral genomes are statistically defined but individuall
y indeterminate. RNA viruses are able to accommodate their average nuc
leotide sequences to changes in environment. A parameter used to quant
itate adaptation is fitness, or the relative ability of a virus to pro
duce infectious progeny. Repeated transfers of one or a few particles
(bottleneck events) generally lead to fitness losses. In contrast, lar
ge population passages allow competitive optimisation of mutant genome
s and fitness gains. Of relevance to medical practice is the ability o
f viral quasispecies to overcome selective pressures imposed by vaccin
es and antiviral agents. particularly dramatic have been the systemati
c isolations of HIV-1 mutants resistant to antiretroviral inhibitors i
n treated individuals. In addition to the ability of HIV-1 quasispecie
s to generate many mutant genomes in short times, calculations of muta
tion frequencies in the pol gene of HIV-1 populations have documented
that mutations related to resistance to antiretroviral inhibitors pree
xist in the mutant swarms of HIV-1 quasispecies. It is not possible at
present to anticipate whether a suitable drug cocktail may be capable
of sustained inhibition of HIV-1 replication without selection of mut
ants resistant to the combination of antiviral agents. (C) 1997 by Joh
n Wiley & Sons, Ltd.